世界のバイオ医薬品・ワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Biopharmaceutical and Vaccines Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12097
• 出版社/出版日：GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、バイオ医薬品・ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオ医薬品・ワクチンの種類別市場規模（バイオ医薬品、ワクチン製造）、用途別市場規模（製薬産業、臨床診断、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・バイオ医薬品・ワクチンの市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Pfizer、Sanofi、Roche、Abbott、Biogen Idec、Regeneron Pharmaceuticals、Alexion Pharmaceuticals、Johnson and Johnson、GlaxoSmithKline、Merck、Lonza、Boehringer Ingelheim、Rentschler
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：バイオ医薬品、ワクチン製造
・用途別分析2016年-2026年：製薬産業、臨床診断、科学研究、その他
・バイオ医薬品・ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・バイオ医薬品・ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・バイオ医薬品・ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・バイオ医薬品・ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン
・バイオ医薬品・ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Biopharmaceutical and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biopharmaceutical and Vaccines size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Biopharmaceutical and Vaccines market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Biopharmaceutical and Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Biopharmaceutical
Vaccine Production

Market segment by Application, can be divided into
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others

Market segment by players, this report covers
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical and Vaccines
1.2 Classification of Biopharmaceutical and Vaccines by Type
1.2.1 Overview: Global Biopharmaceutical and Vaccines Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2020
1.2.3 Biopharmaceutical
1.2.4 Vaccine Production
1.3 Global Biopharmaceutical and Vaccines Market by Application
1.3.1 Overview: Global Biopharmaceutical and Vaccines Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceuticals Industry
1.3.3 Clinical Diagnosis
1.3.4 Scientific Research
1.3.5 Others
1.4 Global Biopharmaceutical and Vaccines Market Size & Forecast
1.5 Global Biopharmaceutical and Vaccines Market Size and Forecast by Region
1.5.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biopharmaceutical and Vaccines Market Size by Region, (2016-2021)
1.5.3 North America Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
1.5.4 Europe Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
1.5.6 South America Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biopharmaceutical and Vaccines Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical and Vaccines Market Drivers
1.6.2 Biopharmaceutical and Vaccines Market Restraints
1.6.3 Biopharmaceutical and Vaccines Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Biopharmaceutical and Vaccines Product and Solutions
2.1.4 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Biopharmaceutical and Vaccines Product and Solutions
2.2.4 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Biopharmaceutical and Vaccines Product and Solutions
2.3.4 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Biopharmaceutical and Vaccines Product and Solutions
2.4.4 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Biopharmaceutical and Vaccines Product and Solutions
2.5.4 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Biogen Idec
2.6.1 Biogen Idec Details
2.6.2 Biogen Idec Major Business
2.6.3 Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
2.6.4 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Biogen Idec Recent Developments and Future Plans
2.7 Regeneron Pharmaceuticals
2.7.1 Regeneron Pharmaceuticals Details
2.7.2 Regeneron Pharmaceuticals Major Business
2.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
2.7.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.8 Alexion Pharmaceuticals
2.8.1 Alexion Pharmaceuticals Details
2.8.2 Alexion Pharmaceuticals Major Business
2.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
2.8.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Alexion Pharmaceuticals Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
2.9.4 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
2.10.4 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 GlaxoSmithKline Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Biopharmaceutical and Vaccines Product and Solutions
2.11.4 Merck Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Merck Recent Developments and Future Plans
2.12 Lonza
2.12.1 Lonza Details
2.12.2 Lonza Major Business
2.12.3 Lonza Biopharmaceutical and Vaccines Product and Solutions
2.12.4 Lonza Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Lonza Recent Developments and Future Plans
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
2.13.4 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Boehringer Ingelheim Recent Developments and Future Plans
2.14 Rentschler
2.14.1 Rentschler Details
2.14.2 Rentschler Major Business
2.14.3 Rentschler Biopharmaceutical and Vaccines Product and Solutions
2.14.4 Rentschler Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Rentschler Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biopharmaceutical and Vaccines Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceutical and Vaccines Players Market Share
3.2.2 Top 10 Biopharmaceutical and Vaccines Players Market Share
3.2.3 Market Competition Trend
3.3 Biopharmaceutical and Vaccines Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biopharmaceutical and Vaccines Revenue and Market Share by Type (2016-2021)
4.2 Global Biopharmaceutical and Vaccines Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2016-2021)
5.2 Biopharmaceutical and Vaccines Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
6.2 North America Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
6.3 North America Biopharmaceutical and Vaccines Market Size by Country
6.3.1 North America Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
6.3.2 United States Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
6.3.3 Canada Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
6.3.4 Mexico Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
7.2 Europe Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
7.3 Europe Biopharmaceutical and Vaccines Market Size by Country
7.3.1 Europe Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
7.3.2 Germany Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
7.3.3 France Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
7.3.5 Russia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
7.3.6 Italy Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
8.2 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
8.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region
8.3.1 Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2016-2026)
8.3.2 China Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8.3.3 Japan Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8.3.4 South Korea Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8.3.5 India Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
8.3.7 Australia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
9.2 South America Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
9.3 South America Biopharmaceutical and Vaccines Market Size by Country
9.3.1 South America Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
9.3.2 Brazil Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
9.3.3 Argentina Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2016-2026)
10.2 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2016-2026)
10.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country
10.3.1 Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2016-2026)
10.3.2 Turkey Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
10.3.4 UAE Biopharmaceutical and Vaccines Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Biopharmaceutical and Vaccines Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biopharmaceutical and Vaccines Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biopharmaceutical and Vaccines Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biopharmaceutical and Vaccines Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Biopharmaceutical and Vaccines Product and Solutions
Table 9. Novartis Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Biopharmaceutical and Vaccines Product and Solutions
Table 13. Pfizer Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Biopharmaceutical and Vaccines Product and Solutions
Table 17. Sanofi Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Biopharmaceutical and Vaccines Product and Solutions
Table 21. Roche Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Biopharmaceutical and Vaccines Product and Solutions
Table 25. Abbott Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 27. Biogen Idec Major Business
Table 28. Biogen Idec Biopharmaceutical and Vaccines Product and Solutions
Table 29. Biogen Idec Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Regeneron Pharmaceuticals Major Business
Table 32. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
Table 33. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Alexion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Alexion Pharmaceuticals Major Business
Table 36. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product and Solutions
Table 37. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 39. Johnson and Johnson Major Business
Table 40. Johnson and Johnson Biopharmaceutical and Vaccines Product and Solutions
Table 41. Johnson and Johnson Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 43. GlaxoSmithKline Major Business
Table 44. GlaxoSmithKline Biopharmaceutical and Vaccines Product and Solutions
Table 45. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Merck Corporate Information, Head Office, and Major Competitors
Table 47. Merck Major Business
Table 48. Merck Biopharmaceutical and Vaccines Product and Solutions
Table 49. Merck Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Lonza Corporate Information, Head Office, and Major Competitors
Table 51. Lonza Major Business
Table 52. Lonza Biopharmaceutical and Vaccines Product and Solutions
Table 53. Lonza Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 55. Boehringer Ingelheim Major Business
Table 56. Boehringer Ingelheim Biopharmaceutical and Vaccines Product and Solutions
Table 57. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Rentschler Corporate Information, Head Office, and Major Competitors
Table 59. Rentschler Major Business
Table 60. Rentschler Biopharmaceutical and Vaccines Product and Solutions
Table 61. Rentschler Biopharmaceutical and Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Players (2019-2021)
Table 63. Global Biopharmaceutical and Vaccines Revenue Share by Players (2019-2021)
Table 64. Breakdown of Biopharmaceutical and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Biopharmaceutical and Vaccines Players Head Office, Products and Services Provided
Table 66. Biopharmaceutical and Vaccines Mergers & Acquisitions in the Past Five Years
Table 67. Biopharmaceutical and Vaccines New Entrants and Expansion Plans
Table 68. Global Biopharmaceutical and Vaccines Revenue (USD Million) by Type (2016-2021)
Table 69. Global Biopharmaceutical and Vaccines Revenue Share by Type (2016-2021)
Table 70. Global Biopharmaceutical and Vaccines Revenue Forecast by Type (2021-2026)
Table 71. Global Biopharmaceutical and Vaccines Revenue by Application (2016-2021)
Table 72. Global Biopharmaceutical and Vaccines Revenue Forecast by Application (2021-2026)
Table 73. North America Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Biopharmaceutical and Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Biopharmaceutical and Vaccines Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biopharmaceutical and Vaccines Picture
Figure 2. Global Biopharmaceutical and Vaccines Revenue Market Share by Type in 2020
Figure 3. Biopharmaceutical
Figure 4. Vaccine Production
Figure 5. Biopharmaceutical and Vaccines Revenue Market Share by Application in 2020
Figure 6. Pharmaceuticals Industry Picture
Figure 7. Clinical Diagnosis Picture
Figure 8. Scientific Research Picture
Figure 9. Others Picture
Figure 10. Global Biopharmaceutical and Vaccines Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Biopharmaceutical and Vaccines Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Biopharmaceutical and Vaccines Revenue Market Share by Region (2016-2026)
Figure 13. Global Biopharmaceutical and Vaccines Revenue Market Share by Region in 2020
Figure 14. North America Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Biopharmaceutical and Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Biopharmaceutical and Vaccines Market Drivers
Figure 20. Biopharmaceutical and Vaccines Market Restraints
Figure 21. Biopharmaceutical and Vaccines Market Trends
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Sanofi Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Abbott Recent Developments and Future Plans
Figure 27. Biogen Idec Recent Developments and Future Plans
Figure 28. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 29. Alexion Pharmaceuticals Recent Developments and Future Plans
Figure 30. Johnson and Johnson Recent Developments and Future Plans
Figure 31. GlaxoSmithKline Recent Developments and Future Plans
Figure 32. Merck Recent Developments and Future Plans
Figure 33. Lonza Recent Developments and Future Plans
Figure 34. Boehringer Ingelheim Recent Developments and Future Plans
Figure 35. Rentschler Recent Developments and Future Plans
Figure 36. Global Biopharmaceutical and Vaccines Revenue Share by Players in 2020
Figure 37. Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Biopharmaceutical and Vaccines Revenue Market Share in 2020
Figure 39. Global Top 10 Players Biopharmaceutical and Vaccines Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Biopharmaceutical and Vaccines Revenue Share by Type in 2020
Figure 42. Global Biopharmaceutical and Vaccines Market Share Forecast by Type (2021-2026)
Figure 43. Global Biopharmaceutical and Vaccines Revenue Share by Application in 2020
Figure 44. Global Biopharmaceutical and Vaccines Market Share Forecast by Application (2021-2026)
Figure 45. North America Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
Figure 46. North America Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
Figure 47. North America Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
Figure 48. United States Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
Figure 52. Europe Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Europe Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
Figure 54. Germany Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Biopharmaceutical and Vaccines Revenue Market Share by Region (2016-2026)
Figure 62. China Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
Figure 69. South America Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
Figure 70. South America Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Biopharmaceutical and Vaccines Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Biopharmaceutical and Vaccines Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Biopharmaceutical and Vaccines Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Biopharmaceutical and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source

Global Biopharmaceutical and Vaccines Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F2793 2019年9月23日 117Pages
本調査レポートは、バイオ医薬品およびワクチンの世界市場について調べ、まとめました。種類別セグメントは、バイオ医薬品、ワクチン製造等、用途別セグメントは、製薬産業、臨床診断、科学研究、その他等に区分しました。バイオ医薬品およびワクチンの世界市場概観、企業動向、企業別バイオ医薬品およびワクチンシェア、市...

ワクチン市場：世界及び中国市場分析・予測（～2024年）

Vaccines Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT6633 2019年10月11日 150Pages
「ワクチン市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるワクチン市場について調査・分析したレポートで、ワクチンの世界市場動向、市場規模、主要企業情報などが含まれています。ワクチンのタイプ別には、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他に分けて分析し、地域別に...

世界のバイオ医薬品用包装市場 2021：企業別、地域別、種類・用途別

Global Biopharmaceutical Packaging Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A14239 2021年7月 100Pages
当調査資料では、バイオ医薬品用包装のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオ医薬品用包装の種類別市場規模（プラスチック・ポリマー、紙・板紙、ガラス、アルミホイル、その他）、用途別市場規模（経口薬、注射剤、その他）、地域別市場規模（北米、アメ...

DT(2種混合)ワクチン市場：世界及び中国市場分析・予測（～2024年）

DT-Based Combined Vaccines Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT2145 2019年10月8日 142Pages
「DT(2種混合)ワクチン市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるDT(2種混合)ワクチン市場について調査・分析したレポートで、DT(2種混合)ワクチンの世界市場動向、市場規模、主要企業情報などが含まれています。DT(2種混合)ワクチンのタイプ別には、2疾患以上、1...

世界の家禽ワクチン市場 2021：企業別、地域別、種類・用途別

Global Poultry Vaccines Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12600 2021年7月 105Pages
当調査資料では、家禽ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。家禽ワクチンの種類別市場規模（液体ワクチン、凍結乾燥ワクチン）、用途別市場規模（チキン、アヒル・ガチョウ、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、...

世界のmRNA癌ワクチン・治療市場 2021：企業別、地域別、種類・用途別

Global mRNA Cancer Vaccines and Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12482 2021年7月 95Pages
当調査資料では、mRNA癌ワクチン・治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。mRNA癌ワクチン・治療の種類別市場規模（腺癌、粘液性癌、腺扁平上皮癌）、用途別市場規模（感染症、がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のバイオ医薬品用機器市場 2021：企業別、地域別、種類・用途別

Global Biopharmaceutical Equipment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A11720 2021年7月 95Pages
当調査資料では、バイオ医薬品用機器のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオ医薬品用機器の種類別市場規模（API機器、調合機械、薬用破砕機、漢方薬加工機、医薬品水機器、医薬品包装機、薬物検査機器、その他）、用途別市場規模（製薬会社、その他）...

世界のバイオ医薬品用研究所機器市場 2021：企業別、地域別、種類・用途別

Global Biopharmaceutical Lab Equipment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A11721 2021年7月 95Pages
当調査資料では、バイオ医薬品用研究所機器のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオ医薬品用研究所機器の種類別市場規模（前処理、反応、分析・試験、その他）、用途別市場規模（研究機関、製薬工場）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の大人・小児用ワクチン市場 2021：企業別、地域別、種類・用途別

Global Adult and Pediatric Vaccines Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A14907 2021年7月 101Pages
当調査資料では、大人・小児用ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。大人・小児用ワクチンの種類別市場規模（大人用ワクチン、小児用ワクチン）、用途別市場規模（病院、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

豚コレラ(CSF)ワクチン市場：世界及び中国市場分析・予測（～2024年）

Classical Swine Fever Vaccines Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT1423 2019年10月8日 149Pages
「豚コレラ(CSF)ワクチン市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における豚コレラ(CSF)ワクチン市場について調査・分析したレポートで、豚コレラ(CSF)ワクチンの世界市場動向、市場規模、主要企業情報などが含まれています。豚コレラ(CSF)ワクチンのタイプ別には、組織培...

世界のバイオ医薬品およびワクチン市場予測（～2024年）：企業別、地域別、種類・用途別 Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases. Scope of the Report: The global Biopharmaceutical …
世界のバイオ医薬品およびワクチン生産市場予測（～2024年）：企業別、地域別、種類・用途別 Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease. Scope of the Report: The global Biopharmaceutical and Vaccine Production market is…
世界のバイオ医薬品用包装市場 2021：企業別、地域別、種類・用途別 The Biopharmaceutical Packaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
世界のバイオ医薬品用研究所機器市場 2021：企業別、地域別、種類・用途別 The Biopharmaceutical Lab Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界のバイオ医薬品用機器市場 2021：企業別、地域別、種類・用途別 The Biopharmaceutical Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…